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Abstract 
Cancer survivorship has been identified as separate stage in cancer treatment posing unique 
issues that arise from the diagnosis of cancer, as well as late effects associated with treatments. 
Evidence shows that cancer survivors demonstrate suboptimal follow-up care, and report high 
levels of unmet needs related to their cancer experience. To improve care for the increasing 
number of cancer survivors in the United States, survivorship care plans (SCPs) have been 
proposed as way to strengthen care coordination and improve patient outcomes. Research 
suggests that SCPs have favorable impact on patient satisfaction and quality of life, however 
little research to date investigates the utility of SCPs in improving patient outcomes, adherence 
to follow-up recommendations, or patients’ confidence in self-care management. To further 
understand the role of SCPs in survivorship care, a pilot implementation of SCPs in colon cancer 
patients was implemented to gather data on the identified gaps.  
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Survivorship Care Plan: A Pilot Implementation in Colon Cancer 
 
 According to the Surveillance, Epidemiology, and End Results (SEER) program, cancer 
incidence has declined by approximately 1% annually over the last 10 years; however, the 
number of cancer survivors has steadily increased, with estimates of 15.5 million people in the 
United States currently living with a cancer diagnosis (Miller et al., 2016). By the year 2026 the 
number of survivors is projected to increase to 20.6 million. Of those affected, colorectal cancer 
is the second leading cancer among men and women, accounting for 1.6 million survivors in the 
United States today; with projected 5 and10 year survival of 65% and 58% respectively (Miller 
et al., 2016).  
Problem Statement 
Cancer survivors face unique disease and treatment related changes that evolve along 
their care continuum. Cancer and its related treatment is known to cause atypical presentation of 
common health conditions, increased risk for infections, accelerated age related changes, 
recurrence and increased risk for acquisition of secondary cancers (McCabe et al., 2013). 
Additionally, cancer survivors experience a spectrum of psychosocial, financial, emotional, and 
spiritual challenges related to their cancer experience (Center for Disease and Control [CDC], 
2016).  Hematology and oncology specialist, as well as larger organizations that guide oncology 
care such as the American Society of Clinical Oncology (ASCO), the CDC, and the National 
Cancer Institute (NCI) recognize that cancer survivors have complex needs which require 
tailored risk assessments, and personalized care planning (Hewitt, Greenfield & Stoval, 2005). 
The 2005 Institute of Medicine (IOM) report illuminated the under-addressed needs of cancer 
survivors in current practice and proposed the integration of survivorship care plans (SCP) to 
address the comprehensive needs of cancer patients. The report recognized survivorship to be a 
SURVIVORSHIP CARE PLAN  
 
4 
distinct phase in cancer care, and recommended that upon completion of cancer treatment, 
patients receive a comprehensive care plan summary and follow-up care plan that can be used 
across health care specialties to optimize care and outcome for patients along their survivorship 
trajectory (Hewitt, Greenfield, & Stovall, 2005). Following the release of the IOM report, the 
Center of Excellence (COE) was founded by the LIVESTRONG foundation, which has served to 
pilot and research survivorship care strategies (Campell et. al., 2011). In response to these 
initiatives American college of Surgeons (ACoS) Commission on Cancer (CoC) announced its 
mandate for SCP implantation; the most recent accreditation requirements propose that 
accredited cancer centers should have provided SCPs beginning in 2015 to 10% of patients who 
meet survivorship criteria. Survivors are to receive a survivorship care plan at completion of 
initial cancer treatment, with incremental increases annually to reach projections 75% of 
qualifying patients receive a SCP by 2018 (CoC, 2014). 
Purpose and Rationale 
 
 A high quality SCP would provide four essential elements: description of specific cancer 
diagnosis, treatments received, instruction for follow-up care, and health promotion 
recommendations. These elements would provide an explanation of associated late and long-term 
effects (LLTE) and foster adherence for disease surveillance and secondary cancer screening. In 
addition the SCP would include resources to for healthy lifestyle recommendation, disease 
prevention, and coping and psychosocial support (Jabson, 2015).  The integration of a high 
quality SCP not only serves as way to improve satisfaction and adherence to follow-up 
recommendations, but also serves as a way to instill confidence in self-efficacy in health 
promotion and disease prevention.  
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Background and Significance 
 
With a survival rate of 84% 12 months post treatment, adults with colorectal cancer are 
projected to account for a large percentage of long-term cancer survivors (Faul, et al., 2012). 
Despite favorable survival statistics, 20-40% of colorectal cancer survivors go onto to develop 
secondary malignancies (NCI, 2013). In addition, depression, chronic fatigue, body image 
concerns, bowel dysfunction, and sexual dysfunction are among the common adverse sequela for 
colon cancer survivors (Faul et al., 2012). Unfortunately many colorectal patients experience 
poorly coordinated care after treatment. This results in distress and unmet needs following their 
cancer care. Only 50% of patients report satisfaction with care addressing their psychosocial 
problems (Wieldraaijer et al., 2016). These findings are congruent with the IOMs national report 
by Hewitt, Greenfield, and Soval (2005), “From Cancer Patient to Cancer Survivor: Lost in 
Transition”, which emphasized that personalized and well- coordinated care planning is 
imperative to meet the complex aftercare needs for colon-cancer survivors.  
Despite acknowledged value of SCPs, integration and implementation in practice has 
been slow; to date less than half of the LIVESTRONG survivorship centers of excellence sites 
are delivering SCPs in accordance to the IOM and CoC’s current recommendations (Kvale, 
2016). The process of creating and disseminating SCPs is a resource-intensive process, posing 
significant challenges in many health care delivery systems (Brennan, Gormally, Butow, & 
Spillane, 2014). Lag in implementation is likely exacerbated by failure of SCP’s to demonstrate 
conclusive evidence that SCP delivery improves outcomes of cancer survivors, as concluded by 
Mayer, Birken, Check, and Chen (2015). Unfortunately many of the randomized control trials 
(RCTs) conducted and reviewed, demonstrate flawed design, and poorly selected variable 
measurements (Mayer, Birken, Check,  & Chen, 2015). Recent published data however, has 
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demonstrated a more promising shift in outcomes. Kvale, et al. (2016) conducted an RCT with 
79 cancer survivors, where usual SCP delivery was compared to “Patient owned SCP” and 
focused coaching session. A Patient owned SCP was described as an individualized care plan 
that is created during a focused coaching session. The intervention group reported lower social 
role limitations (p=0.014) and demonstrated higher self-reported health (p=0.017).  Significant 
changes were also observed in several quality of life (QOL) domains: physical role (p=0.0009), 
bodily pain (p= 0.03), and emotional role (p= 0.04) were demonstrated and depression was 
significantly decreased (p= 0.003) (Kvale, et al., 2016). These findings provide evidence to 
support not only SCPs, but also emphasize the importance of the delivery, suggesting that 
dedicated survivorship visits are useful to enhance SCP use for patients. Similarly Palmer, et al. 
(2015) utilized survivorship visits to deliver SCPs in a pilot study of 139 breast cancer survivors; 
each participant attended a “survivorship visit” where a SCP was delivered and explained., At 
the end of the visit participants completed a survey assessing satisfaction, use of SCP material, 
knowledge of care, and care coordination. The same survey was used three months post visit, and 
compared to baseline data. Results demonstrated high satisfaction, with a report of 90% of 
participant being satisfied or more with the SCP. In addition, patient perceived knowledge about 
follow-up care, and care coordination were significantly improved (all P< 0.001) (Palmer et 
al.,2015). In a cross-sectional study of 1129 colon cancer patients demonstrated similar findings 
with SCPs, with a satisfaction rate of greater than 87% and reported use of SCP in care 
coordination by 69% of participants (Frick et al., 2017).  Satisfaction and QOL metrics are 
heavily studied in the body of SCP research. While satisfaction and QOL serve utility in SCP 
appraisal, metrics pertaining to outcomes are critically important to quantify and little research 
has focused on these areas. Hawkins et al. (2015) evaluated adherence to recommended follow-
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up guidelines in 593 cancer survivors, using a cross sectional design. The sample included 
survivors who received verbal explanation of follow-up instruction in conjunction with written 
instruction (SCP), one or the other, or none at all. It was found that survivors who received 
specific follow-up instructions from health care providers, verbal or written, were associated 
with adherence to guide line recommendation follow-up and screening. Colonoscopy’s are part 
of the National Comprehensive Cancer Network (NCCN) (2017), recommendation for follow-up 
care for all stages of colon cancer and play a crucial part in the identification of colon cancer 
recurrence. Adherence to colonoscopies was significantly greater (p=0.05) if a patient received 
specific instruction for follow-up (Hawkins et al., 2015). Confidence is an important indicator for 
appropriate self-management of disease. Rosenberg et al. (2015) examined SCPs and their 
impact on self-management in a cohort study of 1615 cancer survivors. At one year following the 
receipt of SCP at an individualize risk associated visit, 94% of survivors felt more confident 
communicating about their treatment, 90% were more confident in recognizing signs/symptoms 
to report and 98% were more aware of community services and programs (Rosenberg et al., 
2015)  
A hospital system that is National Cancer Institute-designated cancer center was 
identified for implementation of a Doctorate of Nursing Practice project to facilitate effective 
pilot implementation of SCP in colon cancer patients using a developed SCP that can be adapted 
to the current electronic medical record (EMR). This hospital organization lacked a uniform 
mechanism to deliver and meet the most recent updates for CoC accreditation despite serving an 
estimated 130,000 cancer patients at its combined sites annually (Etzioni et al., 2016). At this 
particular site it serves an estimate of 200 new colorectal patients annually (Etzioni et al., 2016). 
Although the CoC accreditation is not mandatory to deliver cancer treatment, loss of 
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accreditation would be a significant insult to this hospitals reputation as a recognized leader in 
cancer care (Etzioni et al., 2016). The goal of addressing the fragments in care for cancer 
survivors is to shift current methods of care delivery to utilization of comprehensive, individually 
tailored care plans that support seamless post-treatment care to all cancer survivors. Additionally 
this will serve to provide access to adequate tools, resources and guidance to patients, family 
members, primary care providers, and others in the communities at large that are involved with 
cancer care. These assumptions lead to the need for a pilot implementation of SCPs and 
development of the PICO question: In colon cancer survivors(P), how does a survivorship care 
plan(I) compared to standard follow up care(C) affect confidence in self-care, satisfaction, and 
adherence to NCCN follow-up recommendations? (O) 
Search Strategy 
 To address the clinical questions regarding SCPs in colon cancer survivors, an exhaustive 
search of current evidence was performed. An online database search of CINHAL, Medline, and 
PsychINFO using keywords and Boolean connectors was used to obtain all available literature 
concerning the clinical questions of interest. Search was initiated in January 2017, and updated 
through March 2017. Keywords included: cancer survivor, neoplasm, colon cancer, colorectal 
neoplasm, care plan, survivorship care plan, follow-up care, adherence, follow-up care, 
satisfaction, self-efficacy, self-management, and confidence. The initial search was intended to 
include data on all malignancies; searching title and abstracts in each database for (cancer 
survivor or neoplasm) AND (care plan or survivorship care plan). This resulted with 376 from 
CINAHL, 324 from Medline, and 43 from psychINFO. The search was further refined by the 
following limits: peer reviewed studies, publication in English, Adults, and publication within 
the last five year; resulting in 176 from CINAHL, 67 from Medline, and 26 from PsychINFO.  
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The search was altered to examine colorectal cancer by adding (colon cancer or colorectal 
neoplasm) with AND Boolean to each search. This generated 22, 25 and 32 from CINAHL, 
Medline and psychINFO respectively. To focus on the clinical questions of interest; 
(satisfaction), (confidence or self-efficacy), (confidence or self-management), and (adherence or 
follow-up care) were added independently and in combination to initial search and refined 
colorectal search on each database. Demonstration of search can been found in Appendix A 
(CINAHL), Appendix B (Medline), and Appendix C (PsychINFO).  
Saturation was met with the addition of focused keyword search; a robust yield of 
abstracts 62 were assessed and approximately 30 studies were selected for further review and 
quality appraisal. Studies were selected if they had strong statistical and methodological 
integrity, relevance to clinical question and population, and clear documentation. Studies were 
discarded if the population had metastatic disease or palliative intent, if they examined health 
care providers only, or had a weak study design. A total of 11 studies, two randomized control 
trials (RCTs), four systematic reviews (SR), four cross sectional studies, and two prospective 
cohort studies (PCS) were selected for further analysis for quality, relevance, and application to 
clinical PICO question (Appendix D).    
Critical Appraisal & Synthesis 
Rapid Critical Appraisal (RCA) was used to ascertain quality and strength of the 11 
selected studies; evaluation of data is found in the evidence table (Appendix D).  All but one 
study utilized quantitative methodology, with exception of one qualitative systematic review. 
The majority of the studies provide high level of evidence; with four level I, four level II, and 
three level VI as demonstrated in synthesis table (Appendix E). Sample sizes ranged from 79-
1615 in the RCT, prospective cohort studies and cross-sectional studies (Appendix E). Thorough 
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description of data analysis was found in 10 of the 11 studies, with each study noting specific 
level of significance (p) standard deviations (sd), confidence interval (CI), and correlation 
coefficient (r). Appraisal of statistical methods found congruency with each study design 
(Appendix D).  
Reliability is confirmed by consistency in outcomes across homogeneous studies, in 
addition each study demonstrated at least one significant finding and reported use of validated 
measurement tools in each investigation. Three studies (2 RCT, 1 PCS) examined SCP with 
focused visits, each study demonstrated significant improvement in satisfaction and at least one 
other metric measured (appendix E). Collectively SCP demonstrated increased patient 
satisfaction (6) increase in care coordination (5) and increase in survivor knowledge (4).  
Validity is confirmed in the RCTs through randomization and use of control. All four of the 
experimental studies (2 RCTs, 2 PCS) used control procedures for false discovery rate, therefore 
increasing their power (Appendix D). Validity is accepted for the four systematic reviews (SR) 
for their comprehensive description of search strategies, use of validated tools for SR, and 
inclusion of published RCTs and report of appropriate patient data (appendix D).  
All 11 studies investigated SCPs, however heterogeneity in content and delivery was 
observed. Three studies (2 cross sectional, and one SR) evaluated treatment summaries (TS) and 
SCPs.  Four studies (two PCS and two RCT) investigate the delivery of individualized SCP with 
a focused survivorship visits. The remaining four studies evaluated SCPs, however consistency 
in SCP methodology was weak between studies (Appendix D).  Outcomes of interest varied; six 
studies evaluated satisfaction, four studies evaluated quality of life, five evaluated patient 
knowledge, eight evaluated care coordination, one evaluated guideline adherence, and one 
evaluated self-efficacy. Across the 11 studies, the use of SCPs resulted in inconclusive results, 
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many studies demonstrated positive outcome, however failed to reach significance (n=6). Studies 
that investigated the use of focused survivorship visits (n=4) demonstrated greater significance in 
results. 
The majority of the studies were done in the United States (n=9), with foreign 
contribution from Canada (n=1) and Australia (n=2). Homogeneity was observed in cancer type, 
9 of the 11 studies evaluated the use of SCPs in breast cancer survivors, therefore a greater 
representation of females (Appendix D).  Although useful for reproducibility in this population, 
it does limit insight to generalizability to other cancers. Despite a mean age variation between 
studies of 37=74.7, most studies provide data from adult cancer survivors between 50-60 years of 
age. No biases were revealed, however homogeneity of demographics could influence data 
outcomes based on role characteristics and tendencies.  
Conclusions 
Despite the variability in the early evidence of SCPs, improved designs and focus on 
implementation has shifted outcomes related to SCPs in recent years. The culmination of 
evidence does demonstrate appreciable improvement in patient care and reported outcomes such 
as care coordination and satisfaction. The generation and dissemination of SCPs demonstrates to 
be an important element in SCP functionality and benefit, and further research efforts should be 
focused to develop strategies that are scalable across settings and disease types. Data regarding 
SCPs and their influence in guideline adherence and confidence in care ownership is sparse, and 
warrants further investigation. The evidence does support that SCPs are beneficial tools in 
survivorship care; however the utility of SCP is greatly improved when patients are provided a 
specific visit to review the care plan and discuss survivorship. Therefore, research suggests 
efforts should be combined to develop workflows where individualize care plans are delivered in 
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person, and reviewed at a focused visit to optimize the effectiveness of SCPs for both patients 
and involved care provided. Utilization of current research to guide quality improvement and 
evidence based practice projects in SCP delivery would be a useful way to generate data and 
improve processes.  
Conceptual Framework and EBP 
Application of the chronic care model (CCM) was adopted to guide the utilization and 
implementation of SCP to colon cancer survivors at the selected academic institution. The CCM 
incorporates six essential elements to facilitate optimal chronic disease care, and has 
demonstrated useful application in larger healthcare systems. Each identified element: 
community, the health system, self-management support, clinical information system, decision 
support and delivery system design; utilizes specific evidence base change concepts (Wagner, 
1998).  Incorporating these elements enhances patient provider communication and encourages 
patient participation in their care through informed decision-making, behavior change and 
utilization of appropriate health care and community resources (Wagner, 1998). This is useful in 
SCP planning by assisting in resource allocation, role organizations, and facilitation of 
communication with patient’s and amongst interdisciplinary teams such as oncology and primary 
care.   
 To facilitate this proposed practice change, The Mayo Clinic Nursing Evidence-based 
Practice Model (MCNEBP) is utilized (Appendix G). The MCNEBP provides guidance to 
facilitate practice change, and quality improvement initiatives through evaluation and application 
of evidence based practice (EBP) (Mayo Clinic, 2017).  This model utilizes a seven-step process, 
which facilitates a unique problem solving approach to improving cancer survivorship care 
through SCP implementation. The MCNEBP stepwise process encourages critical evaluation of 
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the evidence, and comparison of current practice, the evidence, and desired future state (Mayo 
Clinic, 2017). With contextual consideration of the identified stakeholders, and care teams this 
model enhances appropriate application of EBP to guide quality improvement and evidence 
based practice.   
Purpose  To promote the use of SCPs in survivorship care, and develop a standardized method to 
achieve the CoC.3.3 standards, an evidence based practice project was implemented in an adult 
colorectal cancer practice. This population was selected for its short treatment duration, and 
volume of cancer survivors.  Given a six-month time frame for project implementation and 
assessment, these elements were necessary to adequately observe adherence to practice change 
and progress towards meeting accreditation requirements, as well as measuring the effect of 
practice change on patient care. To evaluate the impact of project implementation, the following 
metrics were evaluated: SCP effects on patient knowledge, confidence, and satisfaction, the 
practice adherence to SCP delivery, and systems progress to meet COC 3.3 accreditation 
requirement  
Methods 
The practice intervention included use of a vended product to create a personalized SCP, 
and delivery of SCP at a focused survivorship consultation with a survivorship or oncology 
provider. Prior to project implementation, Institutional review board approval (IRB) was 
obtained from project site, and Arizona State University. The project entailed multi- phase 
implementation. During the planning phase, physicians, nurse practitioners, physician assistance 
and registered nurses in the colon and rectal cancer practice received focused education and 
training for the SCP product, and workflow redesign specific to each professional role. The 
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workflow was designed to maximize multi-disciplinary scope of practice and facilitate optimal 
delivery of SCP for both patients and providers.  At the completion of treatment, oncology 
providers place consult for a “survivorship consult”; this scheduled visit prompts the RN 
coordinator to create the personalized SCP using the vended software product. The RN sends 
draft SCPs to of provider for review, where the document is finalized for delivery at the 
survivorship consult visit. The survivorship visit for colon patients was led by the survivorship 
MD, and survivorship visits for rectal patients was lead by trained oncology physician assistant. 
The visit focused on thorough review and explanation of SCP 
The organization’s cancer registry assisted in retrospective identification of patients who 
were eligible to receive SCPs based on date of diagnosis and had completed therapy prior to pilot 
implementation. Eligibility was determined based upon CoC 3.3 standards and inclusion criteria; 
18 years of age or greater, lives within a 50 mile radius of Phoenix, diagnosed with cancer stage 
I-III, and received treatment with curative intent. 
 Beginning in August 2017 practice change was initiated and identified colorectal (CR) 
cancer patients were scheduled for survivorship consults. Chart review and cancer registry was 
used to capture the baseline number of SCPs delivered to colorectal (CR) cancer survivors prior 
to pilot initiation. To track the number of SCPs delivered chart review of identified patients were 
assessed for documented SCP in medical record. Percentage increase was tracked through 
February 2018. Patient’s perceived knowledge and confidence in self-care, and care satisfaction 
was measured using the modified Confidence in Survivorship Information (CSI) survey. The CSI 
is a 13-item measurement tool used to assess confidence in survivorship using a three point likert 
scale,  response options range from one, “not at all confident” to three, “very confident”. 
Confidence is assessed in two subscales: Confidence in knowledge of cancer diagnosis and 
SURVIVORSHIP CARE PLAN  
 
15 
treatment details (3 items, reliability: 0.77) and knowledge and confidence in health promotion, 
personal cancer risk, disease prevention and available resources (10 items, reliability: 0.95) 
(Palmer, Jacobs, Mao, & Stricker, 2012). Psychometric properties of this tool have been 
evaluated in a sample of 209 diverse cancer survivors, which yielded a two-factor (past and 
future knowledge) that accounted for 58.4% of the variance. With permission three investigator-
developed items to assess satisfaction and health-promotion were added to CSI questionnaire. 
The additional three items utilized a 5-point Likert scale; with responses ranging from one, not at 
all satisfied to five, very satisfied. Surveys were delivered and completed by patients prior to 
their survivorship consultation, and receipt of SCP. In February 2018 DNP student contacted 
survivors who completed initial survey, and received an SCP. Utilizing the IRB approved phone 
script the follow-up CSI survey was completed by using verbatim language of survey. Please see 
appendix I for survey.  
Results 
The total number of identified patients equaled 18, of those 16 received the prescribed 
intervention of a focused survivorship visit, with delivery of a personalized SCP. This reflected 
an 88% adherence to the practice change.  Of the 16 patients who attended their survivorship 
visit, fifteen completed a pre-survey and seven completed a post survey. Data was collected on 
the fifteen patient participants who completed a pre-survey. There were six females and nine 
males, with an average age of 65. Paired T-test analysis with an alpha of .05 was used to analyze 
the knowledge and confidence of survivors’ pre and post intervention, through CSI response. 
Paired analysis demonstrated an overall increase in survivors’ confidence in cancer self-care 
knowledge and care satisfaction after receiving focused survivorship visit and personalized SCP.  
Statistical significance was achieved in improvement of patient’s confidence and knowledge in 
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strategies to prevent disease recurrence or secondary cancer (p= .001); how to prevent (p= .015) 
and how to treat (p=. 018) late and long term physical effects of cancer or it’s treatment; how to 
prevent (p= .045) and treat (p= .047) emotional effects of cancer diagnosis. Overall satisfaction 
with survivorship care improved from an average response of 4 or satisfied to 4.9 or “very 
satisfied” (p= .015) after receiving intervention. For comprehensive statistical findings in each 
area analyzed by CSI survey reference appendix G.  Graphical demonstration of average 
response of each question of CSI survey pre and post intervention is displayed in appendix H.  
Discussion 
 A team-based approach demonstrates to be a useful framework to implement practice 
change, and adoption of SCPs into cancer practice. In addition to the CR practice, the 
organizations breast cancer practice was also include in the pilot. Both patient populations 
demonstrated positively improved confidence and knowledge in survivorship care. When 
comparing outcomes between practices the colorectal cancer demonstrated more significant 
finding in improvement post intervention. This is likely observed due factors involving 
consistency in practice habits by the providers, and adherence to the prescribed workflow. The 
colon and rectal cancer practice remained stable with two providers who were trained in the 
survivorship workflow, use of SCPs tool and recognized the value of providing high quality 
survivorship care. This resulted in appropriate identification of eligible patients and referral to 
survivorship consult. During CR survivorship visits, providers adhered to workflow designed 
visit where personalized SCPs were reviewed, and questions were addressed regarding SCP and 
cancer survivorship. When compared to breast cancer practice, transition occurred with the 
providers responsible for the survivorship consultation visit throughout the project. Due to 
unexpected leave of absence, not all by providers delivering SCPs received the focused training 
SURVIVORSHIP CARE PLAN  
 
17 
on workflow, or valued the importance of SCPs. This resulted in some variation in the 
identification of eligible patients, resulting in missed survivorship consult referrals. These lapses 
in congruency resulted in some variation in breast cancer practice. It was observed where not all 
patients received discussion and review of their care plan at their survivorship visit. This 
comparison confirms what has been demonstrated in previous research, where value and effect of 
SCPs are maximized when delivered by a trained survivorship provider, and elements of the care 
plan discussed in a focused visit.  
 Although improvement, and statistical significance was observed in the areas of CR 
survivor’s confidence and knowledge; generalization of these outcomes must considered in the 
context of a relatively small sample size, which is recognized as a limitation. Additional 
limitations include short timeframe and observation. The restriction to only 6 months of 
observation of intervention limited the DNP student to observation of only the CSI metrics. 
Observation of  at least 12 months would have allowed for more robust data collection, and 
insight to the practice change include larger population size, and additional metrics that evaluate 
patient outcomes and behavior, such as adherence to applicable NCCN follow-up guidelines, and 
to health promotion behavior such as vaccinations, and smoking cessation. The survivorship 
work flow, including the focused survivorship is not absent of labor intensive demand, and 
increased cost with use of vended SCP product, which is a limitation for some practices, 
however this can also be viewed as “value added” to care provided. This is important to discuss, 
because although it may pose some disruption and challenge, over the long-term trajectory, 
improving survivorship care is likely to mediate reduced cost of care due to improving patient’s 
self-efficacy, and health practices. Self-efficacy and optimized health promotion and disease 
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prevention practices is likely to reduce comorbidity, and therefore lessen the burden of 
unnecessary or improper use of health care resources.  
 Although some adjustments are needed to improve provider compliance to practice 
change, ongoing dissemination of practice change is advised. Future efforts should focus on 
delivery process specific to each unique practice, and optimizing SCP tool to benefit each 
practice. Further data collection of patient’s adherence to NCCN follow-up recommendations 
and health promotion practices ought to be completed to add knowledge of SCP efficacy, and 
value in practice.  
Conclusion 
Strategic implementation of a structured survivorship visit and delivery of SCP has 
demonstrated to be an effective framework to improve the care of cancer survivors. Additionally 
the pilot project provides a useful framework to assist in widespread implementation to all cancer 
specialties, which will assist the organization to maintain accreditation as a recognized cancer 
center.  Joining the use of individualized SCPs with a focused visit fosters patient ownership in 
care, and empowers self-management. Through discussion of treatment summary and disease, 
patients glean greater understanding of risks, and awareness to recommended follow up care. 
The SCPs provide tools to promote health and prevent future disease, which in turn can reduce 
healthcare cost by reduction of complications of poor health management, decrease misuse of 
specialty services and increase use of community resources. Overall, the adoption of this 
evidence base practice change encouraged high quality survivorship and generated data that will 
assist to direct and improve survivorship care moving forward.  
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Appendix D 
Evaluation Table 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data Analysis Findings Decision for Use in 
Practice/Application to 
Practice 
Brennan, M., E. 
(2014). 
Survivorship care 
plans in cancer: 
A systematic 
review of care 
plan outcomes 
 
Country: 
Australia 
 
No 
disclosure/COI 
mentioned. 
 
Funded in part by 
“the Friends of 
The Mater 
Foundation 
Not explicitly 
stated; inferred: 
Henderson need 
theory  
Design: SR 
 
Purpose: To 
review evidence 
of SCP 
implementation 
in practice.  
N=2,286 
participants. 
 
Studies N=10  
RCT: n=5 
non RCT: n=5 
 
TC: 
BC, CC, GC 
 
Age range: 37-62 
 
Inclusion criteria: 
original studies 
evaluating written 
care plans for CS, 
and reporting HQOL 
 
Exclusion criteria: 
Articles evaluating 
SCP in metastatic 
disease, and studies 
that evaluated a 
single variable of 
care.  
 
AT: 
N/A 
 
IV1– paper 
based/online SCP 
IV2: 
oncologist/nurse/PCP 
delivered SCPs 
IV3: Other SCP 
templates 
 
DV1: Survivor 
distress 
DV2: CCC 
DV3: oncological 
outcomes. 
DV4: Understanding 
of SCP and FU care  
(also ability to 
Identify FU 
provider.) 
DV6: change in 
unmeet needs. 
 
Cancer survivor 
unmet needs 
scale.  
Multiple likert 
scales 
 
EORTC quality 
of life 
questionnaire.  
 
Breif symptom 
inventory-18 
“QualSyst” tool 
for SR 
 
Descriptive 
statistics,  
Multivariate 
regression and 
T-test used as 
appropriate . 
SCP had no 
significant findings 
in related to 
distress, care 
coordination, 
satisfaction, or 
cancer outcomes. 
 
SCPs improved 
patient’s ability to 
identify clinicians 
responsible for 
survivorship care. 
(p=.005) 
 
SCPs demonstrated 
reduced amount of 
survivors unmet 
needs. (NS) 
 
Survivors rated 
Satisfaction with 
SCPs, 
understanding and 
receptiveness of 
SCP (NS) 
 
 
LOE: I 
 
Strengths: great 
heterogeneity in SCP 
content. Represent data 
from 2,288 cancer 
survivors.   
 
Limitation: small body 
of heterogeneous 
literature; few RCTs.  
 
Studies lack of 
homogeneity amongst 
cancer type and stage of 
disease. 
 
Lack of consistency in 
evaluation tools. 
  
Ceiling effect in SCP 
satisfaction.  
 
Applicability: evidence 
supports favors in 
patient satisfaction and 
self-reported 
understanding of 
survivorship care.  
 
Feasibility: More 
research is needed to 
identify SCPs effects on 
psychological, 
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oncological, and 
resource outcomes.  
 
Hawkins, N., A. 
(2015). 
Examining 
adherence with 
recommendations 
for follow-up in 
the prevention 
among colorectal 
cancer survivors 
 
Country: US 
 
COI/Disclosures:  
None 
acknowledged.  
Not explicitly 
stated: Inferred: 
Health belief 
model 
Design: Cross 
sectional  
 
Purpose: To 
evaluate if 
recommendation 
for FU were more 
effective if 
received in 
written form 
(SCP) or by 
verbal 
instruction.  
 
N=593 
F: n=296 
M: n=295 
 
Age 
> 50: n=28 
50-89: n= 540 
</= 90: n=24 
 
 
TC: Colorectal 
cancer 
 
Setting: 
Community 
survey: CCR 
 
AT: n/a 
 
Inclusion: Non-MC, 
no previous cancer, 
California resident 
at diagnosis, >/=18 
at diagnosis, current 
vital status, no 
participation in 
previous CCR study. 
Absent of do not 
contact flag on CCR 
 
Exclusion: inability 
to complete survey 
related to language 
barrier, physical, or 
mental 
IV 1: Verbal FU 
instruction 
IV 2: Written FU 
instruction 
 
DV1: Adherence to 
guideline 
recommendations  
Prevention 
amongst 
colorectal cancer 
survivors 
(PACCS) 
survey. 
 
General health 
status was 
measured using 
5-point likert 
scale. 
 
 
Questions and 
close ended 
response 
modified from 
the cancer 
control model 
from the NIHS 
to evaluate last 
routine checkup, 
colonoscopy, 
mammogram or 
pap test was. 
Descriptive 
statistics for 
demographics. 
Noted to 
calculated base 
weights for the 
race and 
ethnicity totals. 
 
Rao-scott chi-
square test. 
 
Multivariate 
logistic 
regression  
 
SAS and 
SUDAAN 
version 10 was 
the statistical 
software used.    
Adherence to 
colonoscopy was 
significantly 
increased in 
patients who 
received FU 
instructions 
compared to those 
who received none.  
 
Adherence to 
additional FU 
recommendations 
was increased, but 
not significantly in 
other selected 
domains.  
 
LOE:  IV 
 
Strengths: large sample 
size, homogeneity of 
cancer. Higher 
cooperation rate of 
participants. Diverse 
sampling 
 
Limitations: adjusted 
response rate of only 
46%. Self-reported 
methods do not allow for 
validation of follow-up. 
Under and over 
reporting potential due 
to reliance on participant 
recall. 
 
Applicability: Quality 
and engaged 
communication is  
essential for facilitating 
successful follow up 
care to cancer survivors. 
Oncology nurses can 
play an important role in 
SCP delivery and 
optimizing survivorship 
care coordination and 
outcomes.  
 
Feasibility: Nursing is in 
a strong position to 
monitor health behaviors 
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incompetence.  
 
 
 
 
 
of survivors.  
Jefford, M. 
(2016). A 
randomized 
controlled trial of 
a nurse led 
supportive care 
package 
(SurvivorCare) 
for survivors of 
color rectal 
cancer 
 
Country: 
Australia  
 
Disclosures/COI: 
authors deny 
financial 
relationships.  
Disclosures 
listed. 
Not explicitly 
stated; inferred: 
SCT 
Design: RCT 
 
Purpose: 
evaluate 
effectiveness of 
SCP and care 
package on 
psychological 
distress, HQOL, 
unmet 
informational 
needs, and 
psychosocial 
outcomes in CR 
CS. 
 
 
N: 217 
N I: 106 
N C: 110 
 
Median age: 64 
(M: 52% F:48%) 
 
TC: CC(56%), RC 
(35%), OLS (10%) 
 
SOD: S1 (7%) , S2 
(22%),  S3 (71%) 
 
 
AT: 1 
Inclusion criteria: 
diagnosis of CC  
stage I-III disease, 
treatment with 
curative intent.  >18 
English speaking.  
 
Exclusion criteria: 
deemed too unwell 
to participate, 
previous 
malignancy, or 
enrollment in a 
conflicting 
IV1: SuvivorCare 
IV2: Usual Care 
 
DV1: Psychological 
distress 
DV2: HQOL 
DV3: Change in 
Unmet needs.  
BSI-18 and 
Global Severity 
index (GSI) 
 
European 
organization for 
research and 
treatment 
(EORTC QLQ 
C-30) 
 
Ideals of 
Survivorship 
care survey (self 
developed) 
 
Cancer 
survivors’ unmet 
needs measure 
(CaSUN) 
SPSS statistics. 
Descriptive 
statistics 
T test (Mann-
whitney U)  and 
Chi-square tests 
as appropriate. 
 
Hochberg’s 
modifiy 
Bonferroni test 
for primary 
outcome 
analysis.   
Distress and 
HQOL were 
similar between 
IV1 and IV2 
 
IV1 were 
significantly more 
satisfied with 
multiple aspects of 
post treatment 
care.(p<.05)  
LOE: II 
 
Strengths: strong 
sensitivity with 
Assessment tools are 
validated, have high 
sensitivity, and 
appropriate for selective 
measurements. N>100, 
Diagnosis homogeneity 
 
Limitations: 
Heterogeneity of 
baseline cancer distress 
and time since diagnosis.  
 
Applicability: 
Intervention 
demonstrates useful 
elements in survivorship 
care. Demonstrates 
highest usefulness in 
patients with higher 
CaSUN scores.  
 
Feasibility: Future 
research needs to 
carefully identify study 
endpoints. Revised use 
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supportive care trial.  
 
of Intervention in   
 
Keesing, S. 
(2015). Cancer 
survivors’ 
experiences of 
using 
survivorship care 
plans: A 
systematic review 
of qualitative 
studies 
 
Country: US 
 
Disclosures/COI: 
Authors declare 
no COI 
 
 
Not explicitly 
stated; inferred 
Self-care theory. 
 
Addresses 
knowledge and 
experience 
influences cancer 
patient self- 
reliance and 
responsibility for 
care.  
Design: 
Systematic 
review  
 
Purpose: Review 
and document 
current 
qualitative 
literature that 
examines CS’s 
experience using 
SCPs. 
N: 11 qualitative 
studies.  
Interview (4), 
focused groups (6) 
Action research (1) 
 
Range of number of 
participants: 7-40. 
 
TC:  
BC (7),  
CC (2), 
other (3) 
 
Inclusion criteria:  
>/= 18 y/o, 
publication 2000-
2014, published in 
English.  
 
Exclusion criteria:  
Abstract only, 
studies that 
examined palliative 
phase of disease, or 
experience of cancer 
treatment. 
AT: N/A  
 
 
 
 
 
 
 
 
IV: Use of SCP 
 
DV: CS perspective 
on SCPs and 
experiences of SCP 
use in care.  
KMET (Klose 
method) 14 item 
  
Community 
based 
participatory 
framework. 
 
Individual 
interviews 
Critical 
appraisal using: 
Standard quality 
assessment 
criteria for 
evaluating 
primary 
research papers 
from a variety 
of fields by 
Kmet, lee and 
cook.  
 
SCP significantly 
reduced 
duplication of 
materials, 
improved 
coordination of 
care, and increased 
communication 
between cancer 
survivor and their 
health care 
provider.  
LOE: I 
 
Strengths: first published 
qualitative systematic 
review. 11 databases 
included in search. 
Utilized Validated 
methods/tools for 
conducting systematic 
review.   
 
Limitations: Disparity in 
amount of qualitative 
data.  
 
Applicability/Feasibility:  
SCPs found to be a 
useful practical tool in 
survivorship care. Need 
for continued research to 
examine practical issues 
related to delivery or 
across a variety of care 
contexts.  
 
SURVIVORSHIP CARE PLAN 
A: anal, AT: attrition rate BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CC: colorectal 
cancer, CCC: continuity and coordination of care, CCR: California cancer registry, CE: College degree CHC: childhood cancer, COI: conflict of interest, CS: 
cancer survivors, CSS: cross sectional study CRD: cancer specific distress, CT: chemo therapy, d: Day DV: dependent variable, EOL: end of life, EORTC: 
European organization for research and treatment of cancer  F: female, FU: follow up, G: group, GA: guideline adherence, GC: gynecological cancer, HBM: 
health belief model, HCP: health care provider  HQOL: health related quality of life, HT: hormone therapy, I: intervention, IV: independent variable,  LALTE: 
late and long term effects, mo: month LIFE: living in the furture M: male, MA: mean age, MC: metastatic cancer, MFD: months from diagnosis, N: number, 
NCI: national cancer institute, NS: not significant, PC: palliative care, PD: psychological distress, PCP: primary provider, PR: peer reviewed, PRO: patient 
reported outcomes, PS: patient satisfaction QLS: qualitative study, QTS: quantitative study, R: Rectal, RCT: randomized control trial, S: stage SCP: 
survivorship care plan, SCT: social cognitive theory, SOD: stage of disease, SR: Systematic review, TC: type of cancer, TM: total mastectomy, TS: treatment 
summary TT: type of treatment U: unknown, US: United States, YO: years old 
30 
 
Kenzik, K, M. 
(2016). 
Treatment 
summaries and 
follow-up care 
instructions for 
cancer survivors: 
Improving 
survivor self-
efficacy, and 
healthcare 
utilization 
 
 
Country: US 
 
 
Disclosure/COI: 
unreported 
 
Funding: Grant 
from department 
of health and 
human services. 
Not explicitly 
stated; inferred 
Self-efficacy 
theory.  
 
Design: 
Cross-sectional 
 
Purpose: 
Examine how 
treatment 
summaries (SCP) 
both written and 
verbal are 
associated with 
self-efficacy and 
healthcare 
utilization. 
 
N= 441 
  
MA: 74.7 
F(60%) M (40%) 
 
TC: prostate and BC 
 
Mean time from 
diagnosis: 4.6 years 
 
Setting: Hospital 
based; 12 different 
sites across 
Alabama, Georgia, 
Mississippi, Florida, 
Tennessee 
 
AT= 0 
 
Inclusion Criteria: 
CS who had 
completed 
treatment, follow 
completion of initial 
survey and were >/= 
2 years  
IV1: Delivery of 
Written summary of 
cancer treatment w/ 
verbal explanation of 
SCP by health 
professional  
IV2: written 
summary of SCP w/o 
explanation.   
IV3: Verbal delivery 
of  follow-up care 
plan w/o written 
summary. 
  
 
DV 1: ER Visits 
DV 2: 
hospitalizations.   
 
Stanford chronic 
illness self-
efficacy scale  
 
Study pertinent 
developed 
questions:  
SCP type and 
delivery. 
ER visits in last 
year, 
hospitalized in 
the last year. 
Primary 
analysis: Three 
multiple linear 
regression 
models to 
estimate 
association. 
 
Exploratory 
analysis: 
Mediation 
analysis was 
used to estimate 
association 
between chosen 
variables 
 
Post Hoc 
analysis: 
performed 
 V1 demonstrated 
increased self-
efficacy scores 
(SD=0.27,p=0.009) 
and decreased 
emergency room 
visits and 
hospitalization 
 
DV1 and DV2: 
decreased 
significantly with 
IV1 
LOE: IV 
 
Strengths: large sample 
size, evaluation of 
multiple health care 
sites. Provides 
evaluation of older 
cancer survivors, which 
has been under studied. 
Use of validated 
measurement tool.  
 
Limitations: reliance on 
patient self-report of 
SCP type and delivery.  
Patient-provider 
relationship, and 
recollection of 
information have 
potential to influence 
self-efficacy scores. 
Lack of insight to 
content of SCP, and/or 
standardization of SCPs. 
 
Applicability/feasibility:  
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reported outcomes, PS: patient satisfaction QLS: qualitative study, QTS: quantitative study, R: Rectal, RCT: randomized control trial, S: stage SCP: 
survivorship care plan, SCT: social cognitive theory, SOD: stage of disease, SR: Systematic review, TC: type of cancer, TM: total mastectomy, TS: treatment 
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Exclusion criteria: 
incomplete survey, < 
2 years post 
treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data suggest that SCPs 
influence survivor’s 
behavior, and health 
outcome. Future 
research directed to 
examine how SCPs help 
survivors. Identify 
strategies to effectively 
implement verbal 
explanation of SCP.   
 
 
Klemanski, D., L. 
(2016). 
Survivorship care 
plan preferences 
of cancer 
survivors and 
health care 
providers: A 
systematic review 
and quality 
appraisal of the 
evidence.  
 
Country: US  
 
Disclosure/COI: 
authors declare 
no COI 
 
 
Not explicitly 
states; inferred: 
Explanatory 
theory  
 
Design: SR 
 
Purpose: To 
describe and 
examine the use 
of treatment 
summaries and 
SCP in current 
practice, as well 
as critically 
appraise relevant 
literature 
regarding 
preferences and 
usefulness of 
SCP in practice.  
N: 29 total  
QTS (19) 
RCT (3) 
Pre/post test (1) 
Survey with 
descriptive analysis 
(15) 
QLS(10) 
 
Study 
characteristics:  
Survivor 
perspectives (N=20) 
Cancer survivor 
perspective only 
(N=14) 
Survivor and 
provider perspective 
(N=6) 
TC: BC (n=10) CC 
(n=3) GC (n=1), 
other malignancies 
IV: SCP use  
IV2: usual care 
 
 
Patient variables:  
DV 1: Survivorship 
experiences 
DV 2: quality of care 
DV 3: Satisfaction 
(with collaborative 
communication 
between care 
providers) 
DV4: Perceived gaps 
in CS care 
DV 5: Delivery of 
SCP 
 
Provider variables:  
DV 1 : perceived 
barriers to SCP 
implementation 
Focus groups, 
individual 
interviews  
 
Mixed methods 
appraisal tool.  
 
Transparent 
reporting of 
evaluation with 
non randomized 
design.  
Critical 
appraisal of data 
using: Quality 
assessment tool 
for QTS 
Joanna Briggs 
Institute’s 
qualitative 
assessment and 
review 
instrument.  
PCPs perceived 
enhance 
coordination of 
care with 
oncologist.  
 
SCPs improved 
survivors 
understanding of 
their cancer and 
ongoing 
survivorship care. 
 
 
LOE: I 
 
Strengths: Included large 
body of heterogeneous 
data 
 
Limitations: many 
studies were exploratory 
studies. Narrow gender 
and cancer type focus 
(ie.breast cancer heavily 
researched) 
heterogeneity in SCPs 
format, and health care 
settings.  
 
Applicability/feasibility: 
Demonstrates improved 
care from both provider 
and patient perspective 
in survivorship follow 
up care. Future research 
SURVIVORSHIP CARE PLAN 
A: anal, AT: attrition rate BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CC: colorectal 
cancer, CCC: continuity and coordination of care, CCR: California cancer registry, CE: College degree CHC: childhood cancer, COI: conflict of interest, CS: 
cancer survivors, CSS: cross sectional study CRD: cancer specific distress, CT: chemo therapy, d: Day DV: dependent variable, EOL: end of life, EORTC: 
European organization for research and treatment of cancer  F: female, FU: follow up, G: group, GA: guideline adherence, GC: gynecological cancer, HBM: 
health belief model, HCP: health care provider  HQOL: health related quality of life, HT: hormone therapy, I: intervention, IV: independent variable,  LALTE: 
late and long term effects, mo: month LIFE: living in the furture M: male, MA: mean age, MC: metastatic cancer, MFD: months from diagnosis, N: number, 
NCI: national cancer institute, NS: not significant, PC: palliative care, PD: psychological distress, PCP: primary provider, PR: peer reviewed, PRO: patient 
reported outcomes, PS: patient satisfaction QLS: qualitative study, QTS: quantitative study, R: Rectal, RCT: randomized control trial, S: stage SCP: 
survivorship care plan, SCT: social cognitive theory, SOD: stage of disease, SR: Systematic review, TC: type of cancer, TM: total mastectomy, TS: treatment 
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(n=6) 
 
Settings:  
Cancer Centers 
Oncology clinics 
Tertiary care centers 
Community cancer 
centers 
 
Inclusion: QLS or 
QTS related to 
preference of items 
to be incorporated in 
SCPs, reported by 
CS, care givers, or 
health care 
providers, published 
1/052005-12/2013 
Original work/ PR, 
English,  
 
Exclusion:  
PC/hospice/EOL 
care, pertained 
mortality statistics, 
pediatric or 
adolescent 
oncology, secondary 
works.  
 
AT: N/A 
 
 
 
DV 2: role 
clarification in SCP 
DV 3: Confidence in 
management of CS 
care.  
 
needed to identify and 
prioritize patient 
preferences regarding 
survivorship care, and 
standardized delivery 
across settings.  
SURVIVORSHIP CARE PLAN 
A: anal, AT: attrition rate BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CC: colorectal 
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Kvale, E., A. 
(2016). Patient-
centered support 
in the 
survivorship care 
transition: 
outcomes from 
the patient-owned 
survivorship care 
plan intervention  
 
Country: US 
 
COI/Disclosures: 
three authors 
receive support 
from NIH grant 
P30 CA13148 
 
Funding: Grant 
support from 
American cancer 
society.  
Explicitly stated: 
Derived from 
chronic care 
model of Wagner 
and Care 
transition 
intervention 
model by 
Colemen.  
Design: RCT 
 
Purpose: To 
determine the 
“POST-CARE” 
intervention’s 
impact on patient 
outcomes and 
care coordination.  
N: 79 
I: n-40 
C: n=39 
 
MA, I: 57.23 
MA, C: 59.51 
 
TOC: breast 
 
TOT, I: 
LNB: n=32 
LND: n=17 
CT: n=23 
RT: n=27 
S: n=40 
 
TOT C; 
LNB: n=30 
LND: n=9 
CT: n=18 
RT:n=26 
S: n=39 
 
Inclusion: age >/= 
19y, non-metastatic 
disease, completion 
of treatment with in 
one year.  
 
Exclusion: outside 
of one year of active 
treatment. 
 
AT: 1  
 
IV 1: POSTCARE 
intervention 
 
IV 2: usual care 
 
DV1: HQOL 
DV2: Depression 
DV3: Self efficacy 
and self-management 
 
Health literacy: 
Rapid estimate 
of adult literacy 
in medicine-
short form.  
 
Comorbidity: 
Charleston 
comorbidity 
index 
 
HQOL: 36-item 
short-form 
health survey 
 
Depression:  
PHQ-9  
 
Limitations, 
social 
role/activities: 4-
item social/role 
activities 
limitation.  
 
Self-
management: 
13-item patient 
activation 
measure-short 
form.  
 
Self efficacy: 
Self efficacy for 
managing 
chronic disease 
6-item scale  
SPSS: Version 
22 and SAS 
version 9.4. 
Descriptive 
analysis: 
demographics 
and treatment 
characteristic. 
 
Chi-square test 
for comparison 
between groups 
regarding 
frequency. 
 
Student t test for 
within group 
comparison.  
Generalized 
linear model 
used to examine 
effect of 
intervention 
coordination 
and patient 
reported 
outcomes.  
IV 1: reported 
lower social role 
limitations, 
(p=0.014) and 
trend towards 
higher self-efficacy 
(p=0.07).  
 
IV 1: reported 
higher self 
reported health 
(p=0.017).  
 
IV 1: Three 
domains of HQOL 
had meaningful 
improvement at 3 
mo. FU. 
Physical role: 
(p=0.009) 
Bodily pain 
(p=0.03) emotional 
role (p=0.04) 
 
LOE: II 
 
Strengths: examines 
robust amount of 
variables, using 
validated tools and 
measurements.  
 
Limitations: conducted 
on breast patients only, 
outcomes may not be 
generalizable across all 
cancer types. Modest 
sample size. Limited 
power. Limited time 
window, does not 
capture long-term effect.  
 
Applicability: Data 
supports and emphasizes 
the importance of not 
only providing an SCP 
but also health care 
providers role in 
discussing content.  
 
Feasibility: Need for 
future research to 
examine if/how 
identified health care 
provider can deliver 
SCP interventions 
effectively, timely, and 
impactful.  
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Mayer, D., K. 
(2015). Summing 
it up: An 
integrative 
review of studies 
of cancer 
survivor care 
plans 
 
Country: US 
 
Disclosures/COI: 
none 
 
Funding/bias: 
funded by 
University of 
North Carolina 
University  
cancer Research 
fund and NCI.  
Mentions 
Donabedian 
Model, but 
otherwise no 
explicit theory 
stated. Inferred 
use of 
explanatory 
theory. 
Design: 
Integrative 
Review 
 
Purpose: To 
summarize 
current scientific 
knowledge, and 
empirical data 
regarding SCP in 
adult CS, and 
identification of 
knowledge gaps 
in survivorship 
care. 
N: 42 studies 
 
Populations:  
CS 
HCP 
 
Categories of Focus: 
1.Content of SCP 
2.Dissemination/ 
Implementation 
3.Survivor/provider 
outcomes. 
 
AT: 0 
 
Inclusion Criteria: 
articles must 
include:  results of 
empirical study, CS 
diagnosed at 18 y/o, 
relate to cancer and 
report findings that 
associated with 
SCPs 
 
Exclusion Criteria:  
Abstracts or 
presentations, focus 
on adult survivors of 
COC and non-
empirical data 
 
IV: SCP 
 
DV1: SCP 
dissemination  
DV2: SCP content 
DV3: HCP/survivor 
outcomes  
 
 
Interviews,, 
focus groups and 
surveys. Survey 
tools not 
specified.  
 
Preferred 
reporting items 
for systematic 
reviews and 
meta analysis 
(PRISMA) 
 
Forward 
stepwise 
selection.  
 
Multivariable 
logistic 
regression  
Discrepancy 
between health 
care providers, and 
cancer survivors in 
the content desired  
 
Survivors report 
utility with 
Paper/electronic 
SCPs 
 
Many studies 
failed to study time 
preference of 
delivery. In studies 
that did, patients 
elected right before 
treatment or 
directly after.   
 
Of 10 cancer 
programs only 
12.5% of patients 
received SCP.  
 
SCP receipt 
improved PCP 
reported CCC and 
confidence in 
knowledge 
(P=0.05) 
LOE: I 
 
Strength: Large body of 
evidence evaluated. 
Evaluated both provider 
and patient perspective.  
 
Limitations: Only four 
high evidence studies 
availability. Limited 
generalizability due to 
lack of diversity.  
Lack of systematic 
testing of data collection 
tools.  
 
Applicability: SCP 
receptivity, and 
implementation remains 
low. 
 
Feasibility: Future 
research needed to 
address methodology of 
SCP use, their context 
and their outcomes.   
SURVIVORSHIP CARE PLAN 
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cancer survivors, CSS: cross sectional study CRD: cancer specific distress, CT: chemo therapy, d: Day DV: dependent variable, EOL: end of life, EORTC: 
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Oancea, S., C. 
(2016). 
Psychological 
distress among 
adult cancer 
survivors: 
Importance of 
survivorship care 
plan.  
 
Country: US 
 
COI: declared no 
COI 
 
Funding: none 
 
 
Not explicitly 
stated; inferred 
HBM. 
Design: Cross-
sectional 
 
Purpose:  To 
examine 
association 
between recipient 
of SCP and 
psychological 
distress in adult 
cancer survivors 
post treatment.  
N: 3,191 
 
G1: CS 1-5 y from 
diagnosis 
N:1046 
Median age: 58.85 
F (n=610) 
M (n=436) 
 
Received FCI: n:789 
Recieived TS: n:366 
 
G2: CS >5 y from 
diagnosis 
N:2145 
Median age: 64.52 
F (n=1463) 
M (n=682) 
 
Received SCI: 
n=1424 
Received TS; n=611 
 
Setting: Telephone 
survey based from 
BRFSS registry 
 
Inclusion criteria: 
Cancer diagnosis at 
>/=18y/o, not 
pregnant at time of 
study, >1 year post 
diagnosis.  
 
Exclusion: 
incomplete survey 
completion,  
 
 
 
 
 
IV 1: TS only 
IV: FCI only 
IV: TS + FCI  
IV 4: no TS or FCI 
 
DV 1: PD 
 
Behavioral risk 
factor 
surveillance 
system 
questionnaire.  
 
Cancer 
survivorship and 
anxiety and 
depression 
modules 
Descriptive 
statistics.  
 
Critical 
analysis: SAS b 
9.4, using 
survey 
procedures. 
 
Multivariable 
weighted 
logistic 
regression to 
investigate 
association 
between chosen 
variables. 
Short-term cancer 
survivors: Distress 
was three times 
higher for those 
who received FCI 
only, as compared 
to FCI and TS. 
(AOR=3.14 95% 
CI [1.29-7.65]) 
 
Long-term cancer 
survivors: distress 
was twice as high 
if FCI, but no TS 
was delivered, 
compared to 
receiving FCI and 
TS.  
(AOR= 2.18, 95% 
CI [1.14-4.19]) 
LOE: 
 
Strengths: Large 
sample size. First study 
to investigate long-term 
distress.  
 
Limitations: Sub group 
who received TS, but no 
FCI were under-
represented. Pain 
severity, and other 
comorbid conditions 
could not be controlled 
for or assessed using 
selected survey. 
Questions subject to 
recall bias due to being 
phone survey.   
 
 
Applicability: SCPs can 
be used to enhance short 
and long-term 
psychological well-
being.  
 
Feasibility: Research 
needed to investigation 
of barriers to SCP 
implementation.  
 
SURVIVORSHIP CARE PLAN 
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Palmer, S., C. 
(2015). Outcomes 
and satisfaction 
after delivery of a 
breast cancer 
survivorship care 
plan: Results of a 
multi-center trial 
 
Country 
 
Disclosers/COI: 
Disclosures 
provided by 
author 
 
Funding: Funded 
by 
LIVESTRONG 
foundation.  
Not explicitly 
stated; inferred: 
Theory reasoned 
action. 
 
Explains 
relationship 
between 
attitude/behavior 
and human 
action; 
specifically 
expected 
outcomes to from 
this behavior. 
Design: 
prospective 
cohort study  
 
Purpose: 
Explore the 
outcomes 
associated with 
delivery of 
comprehensive 
SCP to BC 
survivors.   
N: 139 
MA: 53.93 
Mean MFD: 3.43 
Stage at diagnosis:  
Stage 0: n=10 
Stage 1: n=52 
Stage 2 n=51 
Stage 3 n=21 
 
TOT:  
CT; 93 
HT: 96 
 
Setting: Seven NCI 
designated 
comprehensive 
cancer centers and 
their community 
practices.  
 
Inclusion criteria:  
>/= 18 y/o, 
diagnosis and 
treatment of primary 
BC or DCI, 
IV1: Care prior to 
SCP 
IV2: SCP delivery 
 
DV1: SCP utilization 
DV2: satisfaction 
DV3: knowledge 
DV4: CCC 
 
 
Quality of Life: 
Medical study 
short form (SF)- 
12 
 
Use of SCP 
materials: 16-
item 
investigatory 
developed 
survey see table 
2.  
 
Satisfaction: 
global 
satisfaction on 
5-likert scale.  
 
Perceived 
coordination,  
perceived 
knowledge, 
perceived 
provider 
knowledge, and 
Poorly 
described 
statistical 
methods: 
software 
unlisted.   
Descriptive 
statistics for 
demographics. 
Cronchbach’s 
alpha, and t-test 
as appropriate.  
 
SCP utilization: 
IV2: 64% used 
SCPs for decision 
to exercise, 62% 
used it for dietary 
changes, and 62% 
used SCPs for 
directing follow up 
care.  
 
SCP satisfactions: 
90% were satisfied 
with SCP 
 
Knowledge: IV2 
demonstrated 
improved 
perceived personal 
and provider 
survivorship 
knowledge and 
care coordination. 
(P=<0.001) 
 
 
LOE: II 
 
Strengths: well-
characterized sample,  
variety of cancer care 
settings. Pre and post 
assessment was 
obtained, high retention. 
Standardized visits and 
materials across settings.  
 
Limitations: Quasi-
experimental design, 
narrow demographic 
population, use of self-
developed tools. Self 
reported versus chart 
abstraction leaves room 
for mis-reporting. 
 
Applicability: results 
suggest SCPs and 
delivery can be 
standardized across 
diverse settings and 
SURVIVORSHIP CARE PLAN 
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completion of 
cancer therapy, and 
scheduled 
survivorship visit at 
SCOEN. 
Exclusion criteria:  
Unable to complete 
inform consent d/t 
barriers, and 
previous recipients 
of SCP. 
provider 
behavior was 
assessed by  
investigator 
developed 
available by 
request.  
 
 
providers. Useful in 
breast cancer survivors, 
particular those who are 
new survivors.  
 
 
Feasibility:  
Success at all study sites 
with recruiting and 
completion suggest that 
with Institutional 
commitment, and 
financial and logistical 
support SCPs can be 
delivers effectively to 
patients.  
 
Rosenberg, C., A. 
(2015). 
Promotion of 
self-management 
for post treatment 
cancer survivors: 
evaluation of 
risk-adapted visit 
 
Disclosures/COI: 
All authors report 
no conflict of 
interest. 
Disclosures noted 
in article  
 
Funding: none.  
Not explicitly 
stated: Inferred: 
individual and 
family self 
management 
theory 
Design: 
prospective 
cohort study 
 
 
Completed initial 
survey: N=1615 
Completed survey at 
one year: N=488 
 
TC: 
BC: n=1173 
GC::n=131 
CC: n=56 
Other: n=255 
 
Last treatment: 
< 6mo: n=1156 
6-12mo n=175 
>12-18mo: n=284 
 
Setting: Northshore 
medical center 
 
Inclusion: referral to 
program within year 
of treatment 
completion. 
Treatment 
completed at 
IV: SCP w/ Risk 
adapted visit LIFE 
program 
 
DV1: SCP utility 
DV2: lifestyle 
changes 
DV3: wellness goals 
LIFE program 
Pre- and Post 
Risk adapted 
visit 
questionnaire.  
All Surveys 
reviewed, 
tabulated and 
recorded by the 
physician 
director of 
LIFE. 
Descriptive 
statics of 
evaluations 
performed. 
At 1 year, 
respondents report 
SCP with risk 
adapted was useful 
for the following: 
100% useful tool 
to summarize 
medical 
information  97% 
FU care, 85% 
recognizing 
symptoms of 
recurrence, 93% in 
improving health 
and lifestyle 
practices, 
LOE: II 
 
Strengths: Large 
sample size, 6 years of 1 
year survivor FU data 7 
years of comprehensive 
data. Difference in initial 
and 1 year out for BC 
survivors reached 
significance.  
 
Limitations: Lack of 
generalizability to due 
specific population 
characteristic. Results 
could be influenced by 
compliance 
characteristic of 
population. Low 
response rate at 1 year.  
 
Applicability: 
Discussion, and 
explanation of SCP 
assist survivors to 
SURVIVORSHIP CARE PLAN 
A: anal, AT: attrition rate BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CC: colorectal 
cancer, CCC: continuity and coordination of care, CCR: California cancer registry, CE: College degree CHC: childhood cancer, COI: conflict of interest, CS: 
cancer survivors, CSS: cross sectional study CRD: cancer specific distress, CT: chemo therapy, d: Day DV: dependent variable, EOL: end of life, EORTC: 
European organization for research and treatment of cancer  F: female, FU: follow up, G: group, GA: guideline adherence, GC: gynecological cancer, HBM: 
health belief model, HCP: health care provider  HQOL: health related quality of life, HT: hormone therapy, I: intervention, IV: independent variable,  LALTE: 
late and long term effects, mo: month LIFE: living in the furture M: male, MA: mean age, MC: metastatic cancer, MFD: months from diagnosis, N: number, 
NCI: national cancer institute, NS: not significant, PC: palliative care, PD: psychological distress, PCP: primary provider, PR: peer reviewed, PRO: patient 
reported outcomes, PS: patient satisfaction QLS: qualitative study, QTS: quantitative study, R: Rectal, RCT: randomized control trial, S: stage SCP: 
survivorship care plan, SCT: social cognitive theory, SOD: stage of disease, SR: Systematic review, TC: type of cancer, TM: total mastectomy, TS: treatment 
summary TT: type of treatment U: unknown, US: United States, YO: years old 
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Northshore medical  
 
Exclusion: > 18 
months since 
treatment 
completion  
 
 
 
understand their cancer 
experience and have  
potential to promote 
long-term self 
management.  
 
Feasibility: Risk 
adapted visits is resource 
intense; for both creating 
and delivering SCP. RN 
is ideal to establish SCP 
to optimize resources 
and patient outcomes.  
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Appendix E 
Synthesis Table                                           
  
 
 
  Studies 
Brenna
n 
Hawkin
s 
Jefford
 
Keesin
g 
Kenzik
 
Kleman
ski 
Kvale Mayer Oancea
 
Palmer
 
Rosenb
erg 
  
Year 2014 2015 2016 2015 2016 2016 2016 2015 2016 2015 2015 LOE I VI II I VI I II I VI II II Design SR CS RCT SR CS SR RCT SR CS PCS PCS Length N/A 1d 6m N/A 1d N/A 3mo N/A 1d 3mo 1y SCP X X  X X X  X X X  SCPFV   X    X    X TS     X X   X   QOL   NS   NS      SF            SCK            CC       NS     GA            D NS  NS   NS      HB            SE            
  
CC: care coordination CS: cross sectional study D: distress GA: guideline adherence, HB: health behavior 
LOE: level of evidence, PCS: prospective cohort study, NS: Not significant QOL: quality of life,              RCT: randomized control trial, SCK: survivor knowledge, SCP: survivorship care plan,                       
SCPFV: Survivorship care plan and focused visit, SE: Self-efficacy, SF: satisfaction,                                       
TS: treatment summary    
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Appendix F 
Mayo Clinic Nursing Evidence-Based Practice Model   
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Appendix G 
Confidence in Survivorship Information Analysis  
 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) 
95% Confidence 
Interval of the 
Difference 
Upper 
Pair 1 Type - Type2 .207 -1.000 6 .356 
Pair 2 Stage - Stage2 .165 -1.987 6 .094 
Pair 3 Treatments - Treatments2 .413 -1.000 6 .356 
Pair 4 Prevent - Prevent2 -.508 -6.000 6 .001 
Pair 5 Physical Effects  - Physical 
Effects2 
-.505 -4.382 6 .005 
Pair 6 Prevent Physical Effects - 
Prevent Physical Effects2 
-.311 -3.361 6 .015 
Pair 7 Treat Physical Effects - Treat 
Physical Effects2 
-.245 -3.240 6 .018 
Pair 8 Emotional Effects - Emotional 
Effects2 
-.025 -2.521 6 .045 
Pair 9 Prevent Emotional Effects - 
Prevent Emotional Effects2 
-.025 -2.521 6 .045 
Pair 10 Treat Emotional Effects - Treat 
Emotional Effects2 
-.015 -2.500 6 .047 
Pair 11 Community Resources - 
Community Resources2 
-.154 -2.828 6 .030 
Pair 12 Family  Risk - Family  Risk2 -.015 -2.500 6 .047 
Pair 13 Family  information - Family  
information2 
-.025 -2.521 6 .045 
Pair 14 Survivorship care - Survivorship 
care2 
-.621 -3.361 6 .015 
Pair 15 Wellness - Wellness2 -.307 -2.931 6 .026 
Pair 16 Health Promotion - Health 
Promotion2 
.068 -2.335 6 .058 
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Appendix H 
Average Difference Following SCP Intervention  
 
 
 
 
 
 
 
2.7
2.6
2.7
2.2
2.2
2.0
2.1
2.4
2.3
2.3
2.1
2.3
2.3
4.1
3.9
3.9
2.8
2.9
3.0
2.5**
2.5
2.6*
2.6*
2.7
2.7*
2.6*
2.7*
2.7*
2.7*
4.9*
4.7
4.7
Type
Stage
Treatments
Prevent CA
Physical Effects
Prevent Physical Effects
Treat Physical Effects
Emotional Effects
Prevent Emotional Effects
Treat Emotional Effects
Community Resources
Family  Risk
Family  information
Survivorship care
Wellness
Health Promotion
CSI Survey ComparisonPost Pre
** p-value= 0.001 
*   p-value= >0.05 
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Appendix I 
Confidence in Survivorship Information Survey 
   Confidence in Survivorship Information Questionnaire*  
How confident are you about your knowledge of each of the following aspects of your cancer 
and cancer-related follow up care?  
Please select only one box per question. 
Not at all 
Confident 
Somewhat 
Confident 
Very 
Confident 
The type of cancer you have/ had? □ □ □ 
The stage of cancer you have/ had? □ □ □ 
The treatments you received/are receiving for cancer? □ □ □ 
Things you can do to help prevent your cancer from recurring? □ □ □ 
The long-term physical effects you may experience from cancer and 
its treatment? □ □ □ 
Strategies for preventing long-term physical effects of cancer 
treatment?  □ □ □ 
Strategies for treating long-term physical effects of cancer treatment? □ □ □ 
The long-term emotional effects you may experience from cancer and 
its treatments? □ □ □ 
Strategies for preventing long-term emotional effects of cancer 
treatment? □ □ □ 
Strategies for treating long-term emotional effects of cancer 
treatment? □ □ □ 
Community resources available to help you deal with long-term 
effects of cancer and its treatments? □ □ □ 
Whether your family members are at increased risk for cancer? □ □ □ 
How your family members can get information on their risk for 
cancer? □ □ □ 
 
*Used with permission from University of Pennsylvania.  
 
How satisfied are you with the survivorship care you received at Mayo Clinic? 
  Very Satisfied   Satisfied   Neutral   Dissatisfied   Very Dissatisfied 
How your healthcare provider addressed ways to improve wellness? 
  Very Satisfied   Satisfied   Neutral   Dissatisfied   Very Dissatisfied 
How your healthcare provider addressed ways to promote your health? 
  Very Satisfied   Satisfied   Neutral   Dissatisfied   Very Dissatisfied 
